NCT02598453View on ClinicalTrials.gov

PRIOR Study - A Study of Ibandronate (Boniva) in Postmenopausal Women With Osteoporosis or Osteopenia

PHASE4CompletedINTERVENTIONAL
Enrollment

545

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions
Postmenopausal Osteoporosis
Interventions
DRUG

Ibandronate

Either 150 mg oral tablet once monthly or 3 mg IV injection once every 3 months

Trial Locations (60)

10003

New York

10993

West Haverstraw

19610

Wyomissing

23294

Richmond

23298

Richmond

23502

Norfolk

27103

Winston-Salem

27704

Durham

28144

Salisbury

28209

Charlotte

29464

Mt. Pleasant

29569

Loris

30904

Augusta

32605

Gainesville

33186

Miami

33409

West Palm Beach

33901

Fort Myers

34464

Beverly Hills

34471

Ocala

34684

Palm Harbor

36116

Montgomery

37620

Bristol

43213

Columbus

44143

Mayfield

44406

Canfield

47714

Evansville

48236

Detroit

53792

Madison

55318

Chaska

57105

Sioux Falls

57201

Watertown

58104

Fargo

58501

Bismarck

59101

Billings

61820

Champaign

63033

St Louis

64114

Kansas City

68822

Broken Bow

69361

Scottsbluff

71457

Natchitoches

71603

Pine Bluff

73112

Oklahoma City

75231

Dallas

76210

Denton

76508

Temple

78155

Seguin

78229

San Antonio

78238

San Antonio

83814

Coeur d'Alene

85253

Paradise Valley

86403

Lake Havasu City

87106

Albuquerque

89104

Las Vegas

90404

Santa Monica

92083

Vista

92103

San Diego

92108

San Diego

98405

Tacoma

04106

South Portland

48202-2689

Detroit

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02598453 - PRIOR Study - A Study of Ibandronate (Boniva) in Postmenopausal Women With Osteoporosis or Osteopenia | Biotech Hunter | Biotech Hunter